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Natural products often unite structure and function in 
unforeseen ways. Such facets have long driven target-
oriented synthesis and drug discovery campaigns. The 
concerted challenge for the organic chemist is not only 
to orchestrate a sequence of synthetic methods into a 
workable, clever strategy, but also to advance and 
develop methods and tactics in conceptually new ways. 
Indeed, the complex multifunctionalized chemical 
environments of natural products frequently limit the 
effectiveness of a known method to achieve a desired 
reaction. Brønsted acids or bases, Lewis acids or bases, 
organometallics, carbocations, carbanions, radicals, 
carbenoids, ylids, and neutral and ionic species in 
general, will often experience competing interactions 
outside their designed or known roles as reactants or 
reagents. This is true whether they are being used (or 
generated) in a catalytic, additive, redox, spectator or 
stoichiometric sense. At each key step of a targeted 
synthesis, therefore, each chosen method often needs to 
be advanced and optimized, and may be scrutinized on 
the basis of several interrelated criteria (see opposite). 
Such ideals need to be sensibly balanced within a 
multistep synthesis, whether a key building block is 
being constructed or a key coupling step is being 
optimized (or even devised). Herein, we present key 
methods and strategies that were advanced en route to 
uncovering the chemistry and biology of the (1) 
lipopeptides
1
, (2) lipstatins
2
, (3) platensimycins
3
, (4) 
bielschowskysins
4
, (5), cyanosporasides
5
 and (6) the 
kedarcidin chrompohore
6
. Besides developing several 
new methods, the chemistry presented has challenged 
the frontiers of metal and amine catalysis, Lewis acid 
and organometallic couplings, and transannular tactics. 
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